Six Peptide Compounds Dominate 2026 Laboratory Research, Review Finds

A new review from cheat codes identifies BPC-157, TB-500, CJC-1295, Ipamorelin, Selank, and Epithalon as the most studied research peptides in preclinical literature, highlighting their potential implications for future therapeutic development.

May 31, 2026
Six Peptide Compounds Dominate 2026 Laboratory Research, Review Finds

A comprehensive review published by cheat codes has identified six peptide compounds as the most studied in peer-reviewed literature as of 2026, based on their biochemical profiles, citation volumes, and documented in vitro and in vivo outcomes. The analysis, which spans over 25 years of published science, covers BPC-157, TB-500, CJC-1295, Ipamorelin, Selank, and Epithalon, providing a consolidated reference for laboratory researchers.

The review arrives amid growing demand for catalogued, reproducible peptide data in preclinical studies. According to Dr. Marcus Hale, Director of Research Curation at cheat codes, the intent is to offer a reference point grounded entirely in documented laboratory data. The findings are significant because they underscore which compounds are generating the most robust scientific evidence, potentially guiding future research directions and procurement decisions.

BPC-157, a 15-amino acid sequence derived from a protective gastric protein, has been studied for over two decades, with research on tendon-to-bone healing and gastrointestinal mucosal integrity. A 2019 study in the Journal of Physiology - Paris documented accelerated Achilles tendon repair in rat models. TB-500 (Thymosin Beta-4) is a 43-amino acid peptide involved in actin sequestration and cell migration. A 2016 publication in the Annals of the New York Academy of Sciences highlighted its role in cardiac tissue repair pathways after ischemic events.

CJC-1295, a synthetic analogue of growth hormone-releasing hormone (GHRH) with drug affinity complex technology, showed sustained growth hormone elevation over six days in animal and early human cell studies, as reported in a 2006 paper in the Journal of Clinical Endocrinology & Metabolism. Ipamorelin, a selective growth hormone secretagogue, has a selectivity profile that minimizes cross-reactivity with cortisol or prolactin pathways, a distinction documented in a 1998 study in the European Journal of Endocrinology.

Selank, a heptapeptide analogue of tuftsin, has over 30 peer-reviewed studies examining its effects on GABA-A receptor modulation and interleukin-6 expression, with research active in neurological and immunological in vivo frameworks. Epithalon, a synthetic tetrapeptide derived from pineal peptide, is known for telomerase activation; a 2003 study in Neuroendocrinology Letters reported telomere elongation in human somatic cell cultures, with additional findings on circadian rhythm and melatonin synthesis.

The cheat codes review drew exclusively from indexed peer-reviewed publications, in vitro assay data, and documented in vivo animal model outcomes, excluding anecdotal or commercial sources. All six compounds are available for laboratory procurement through Cheat Codes Peptides, which supplies catalogued peptide compounds strictly for research use. The full review and compound specifications are accessible through the cheat codes research library.